Benjamin J. Davies MD is a Professor of Urology at the University of Pittsburgh. He is the Director of the Urologic Oncology Fellowship and is the Chief of Urology at the Hillman Cancer Center at the University of Pittsburgh. He is the Chief of the Health Services Research Division with a focus on health equity and pharmacoepidemiology.

Dr. Davies has published over 200 peer-reviewed articles centering on prostate cancer outcomes, basic science research in genomics, and health service-related topics.  Much of his recent work has centered on influencing physicians’ behaviours with narcotics and with post-operative care decision making.  His clinical practice is focused on robotic prostatectomies, bladder cancer surgery including male/female neobladder reconstruction, kidney cancer surgery including robotic partial nephrectomies, and testicular cancer surgery. Dr. Davies also has an appointment with the School of Public Health in the Center for Pharmaceutical Policy and has focused his time there on pharmacoepidemiology of BCG treatment.

Links to speaker’s research

The Costs of Delayed Generic Drug Entry: Evidence from a Controversial Prostate Cancer Drug Patent

Ensuring Access to Injectable Generic Drugs — The Case of Intravesical BCG for Bladder Cancer

Large Reduction in Opioid Prescribing by a Multi-pronged Behavioral Intervention after Major Urologic Surgery

Anne K. Pelletier Cameron, MD, FRCSC, FPMRS is the James Montie Legacy Professor of Urology at the University of Michigan and Associate Chair of Quality and Safety and Service Chief for the Department of Urology.

She received her undergraduate degree in Science at the University of New Brunswick in Fredericton as a Beaverbrook Scholar graduating magna cum laude. She completed her medical degree at the University of Ottawa followed by residency in Urology at Dalhousie University in Halifax, Nova Scotia.

She came to the University of Michigan in 2007 for a two-year fellowship in Female Pelvic Medicine and Reconstruction after being recruited by Dr. Edward McGuire.  During her fellowship she developed a passion for research and collaboration with our colleagues in Physical Medicine and Rehabilitation.

Dr. Cameron was then recruited to stay at the University of Michigan as an Assistant Professor in Urology in 2009 and has been very productive clinically, in research and education.  Her clinical interests include complex incontinence, female urethral disease, urodynamics and the care of neurogenic lower urinary tract dysfunction (NLUTD).

Dr. Cameron has been the lead of the observational cohort for the NIDDK funded Symptoms of Lower Urinary Tract Dysfunction Network for both LURN I and the ongoing LURN II endeavors.  Other current research includes trials in the care of NLUTD and prevention of urinary tract infections in this vulnerable population.

She has a strong interest in medical education having served as a Doctoring faculty for the medical school as well as the urology clerkship director.  Currently she is part of the residency Core Educational Faculty and Associate FPRMS Fellowship director and gives many educational lectures locally and nationwide.

Dr. Cameron is active with the Society of Women in Urology serving on their Board of Directors currently as President and as their annual meeting planner for 2022.  She is also very active with the AUA serving on the Core Curriculum as well as a member the on the Neurologic Lower Urinary Tract Dysfunction Guideline Committee and is the Chair of the upcoming SUFU/AUA Overactive Bladder Guideline.  Dr. Cameron has also been very active with the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction serving currently on the Executive Committee as Secretary/Treasurer and is the new Deputy Editor in Chief of the organization’s journal Neurourology and Urodynamics.

Links to speaker’s research

Gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on intermittent catheterization

The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction

Treatment of urethral stricture disease in women: A multi‐institutional collaborative project from the SUFU research network

Kirsten Greene, MD, MS, FACS received her undergraduate training from the University of Virginia on full academic scholarship. She received her MD from the Johns Hopkins School of Medicine and completed her general surgery and urology training at the University of California, San Francisco where she also received a Masters in Clinical Research. She specializes in urologic cancers and minimally invasive surgery. Kirsten was Vice Chair and Chief of Urology at the SFVA and Associate Chair for Education and Program Director for the Department of Urology at UCSF until 2019. She was the first woman to achieve the rank of full Professor in the UCSF Department of Urology. In 2019, she became Chair of the University of Virginia Department of Urology and holds the Paul Mellon Endowed Chair in Urology. She became Associate Chief Medical Officer for UVA Health in 2020.  Her research interests include minimally invasive surgery, novel imaging technologies in prostate cancer, resident and physician well-being and burnout, and outcomes in bladder, kidney and prostate cancer. She is the President elect of the Society of Academic Urologists (SAU). She won the UCSF Resident Teaching Award and Peter R. Carroll Mentorship award at UCSF in 2018, the UVA Resident Teaching Award in 2022, and the AUA Mid Career award in 2022.

Links to speaker’s research

Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging

Assessing Contemporary Trends in Female Speakership within Urologic Oncology

Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy

Matthew Bultitude is a Consultant Urological Surgeon at Guy’s and St. Thomas’ Hospital in London specialising in kidney stone management. He trained in London and undertook a fellowship year at the Alfred Hospital in Melbourne. At Guy’s he has been clinical lead for his department and is currently the Clinical Director for transplantation, nephrology and urology. He was Associate Editor of the journal BJUI for 9 years and is a previous Secretary of the Urology section of the Royal Society of Medicine. He is currently a member of the Executive Committee of the Section of Endourology of BAUS.

Links to speaker’s research

Cystinuria: Clinical Practice Recommendation

Medical Expulsive Therapy for Urinary Stones: Future Trends and Knowledge Gaps

Management of renal colic

Dr. Derya Tilki is a Professor of Urology at the Martini-Klinik Prostate Cancer Center and at the Department of Urology, University Hospital Hamburg-Eppendorf in Germany. She obtained her medical degree at the University of Hamburg and received her Urologic residency training in Munich, with research fellowships at Harvard Medical School in Boston and at Weill Cornell Medical Center in New York. Dr. Tilki completed a Uro-Oncology fellowship at UC Davis in Sacramento, USA. Dr. Tilki‘s research is focused on uro-oncology with a particular interest in prostate cancer. She has authored and co-authored more than 300 publications and is an Associate Editor of European Urology Focus. Dr. Tilki is Panel Member of the EAU Prostate Cancer Guidelines.

Links to speaker’s research

Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following
Radical Prostatectomy for Prostate Cancer and the Risk of Death

External Validation of the European Association of Urology Biochemical Recurrence Risk Groups to Predict Metastasis and Mortality After Radical Prostatectomy in a European Cohort

Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death

Caroline Moore is the first woman in the UK to become a Professor of Urology, and was recently awarded the Golden Telescope award. She is an NIHR Research Professor, Head of Urology at University College London and the BAUS/RCS Urology research lead.

She is passionate about improving the diagnostic and treatment pathway for men with prostate cancer, using the latest in imaging technology, decision support and outcomes measurement. This includes a pioneering role in the use of MRI for prostate cancer detection and active surveillance, and the development of focal therapy for prostate cancer.

Links to speaker’s research

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

Medium-term oncological outcomes in a large cohort of men treated with either focal or
hemi-ablation using high-intensity focused ultrasonography for primary localized prostate
cancer

Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study

Tamsin is a Consultant Urological Surgeon and Honorary Associate Professor at University College London (Hospitals). She runs a large multidisciplinary Functional, Reconstructive and Adolescent (FRA) Urology service, with her main interests being urinary tract fistulae, female urethral diverticulum, male and female urethral stricture, complex male and female urinary incontinence, mesh complication surgery and lower urinary tract reconstruction.

She has been the Chair of the BAUS section of Functional, Neurourology and Urodynamics, BAUS Director of Education and the RCS (Eng) Urology Tutor. She is currently; a member of the AUA’s GURS Board of Directors, the EAU’s ESGURS committee, the EAU Urethral Stricture Guidelines Committee, the Vice Chair of the UKCS and the Chair of the EAU Taskforce on EDI. She was awarded the John Anderson Medal by BAUS for outstanding contribution to British urology in 2020.

Links to speaker’s research

European Association of Urology Guidelines on Urethral Stricture Disease (Part 1): Management of Male Urethral Stricture Disease.

European Association of Urology Guidelines on Urethral Stricture Disease Part 3: Management of Strictures in Females and Transgender Patients.

Developing and validating a new nomogram for diagnosing bladder outlet obstruction in women.

Appendix or Ileum-Which is the Best Material for Mitrofanoff Channel Formation in Adults?

Archie Fernando is a Consultant Urological Surgeon at Guy’s and St Thomas’ Hospital in London. She qualified from Cambridge University and University College London. She trained in both open and robotic-assisted surgery; and specialises in renal and testis cancer, and ret-roperitoneal fibrosis (RPF). Archie is part of the specialist RPF team at Guy’s who get referrals from all over the world. She introduced robotic-assisted ureterolysis for the treatment of ureteric obstruction from RPF and set up the first RPF biobank. She is a high volume surgeon in open and robotic-assisted kidney and retroperitoneal surgery including supine RPLND.

Links to speaker’s research

The contemporary role of ureterolysis in Retroperitoneal Fibrosis (RPF) – treatment of last resort or first intent? A prospective analysis of 50 cases.

Nephron-sparing surgery across a nation – outcomes from the British Association of Urological Surgeons 2012 national partial nephrectomy audit.

[18F]-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis, Treatment Stratification, and Monitoring of Patients with Retroperitoneal Fibrosis: A Prospective Clinical Study.

Jo Cresswell is a Consultant Urological Surgeon in the North East of England. In June 2022, Jo became the President of the British Association of Urological Surgeons and over the last year has led the BAUS Widening Participation project. Her clinical and research interests focus on management of bladder cancer including robotic and open cystectomy. Jo has a strong interest in urological training as a previous Training Program Director and Specialty Advisory Committee member. As Clinical Director at the James Cook University Hospital in Middlesbrough she led the team through the COVID pandemic.